Why the study?
Documentation of a decrease in RV wall area and overlying fibrin by two-dimensional transthoracic echocardiography following intrapericardial fibrinolytic administration had not been previously reported in an adult with purulent pericarditis.
Intrapericardial fibrinolytic administration can reduce fibrin content in purulent pericarditis, which can be effectively visualized and measured using two-dimensional transthoracic echocardiography.
Answers are grounded in this paper and cite their sources.
May support echo-guided intrapericardial fibrinolysis in purulent pericarditis; leaves open need for controlled trials.
We describe an adult patient who presented with purulent pericarditis (PP) in whom two-dimensional transthoracic echocardiography demonstrated a marked decrease in the area of the right ventricular (RV) wall together with the overlying fibrin following intrapericardial administration of a fibrinolytic agent. Documentation of this decrease by measurements performed and illustrated on two-dimensional images has not been reported previously in an adult patient with PP, to the best of our knowledge.
No takes yet. Share an insight, caveat, or question.
Abdelsalam et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: